Systemic Immune-Inflammatory Index (SII) as a Biomarker for Metastatic Non-Small Cell Lung Cancer

被引:0
|
作者
Asif, S. [1 ]
Kesireddy, M. [1 ]
Ganti, A. K. [1 ]
Marr, A. [1 ]
Buddharaju, L. N. [1 ]
机构
[1] Univ Nebraska Med Ctr, Hematol Oncol, Omaha, NE USA
关键词
Systemic immune-inflammatory index; NSCLC; Biomarker;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P60.08
引用
收藏
页码:S1167 / S1168
页数:2
相关论文
共 50 条
  • [21] Therapy of Metastatic Non-small Cell Lung Cancer
    Reinmuth, N.
    Groeschel, A.
    Schumann, C.
    Sebastian, M.
    Wiewrodt, R.
    Reck, M.
    PNEUMOLOGIE, 2016, 70 (09): : 567 - 578
  • [22] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [23] Chemotherapy for metastatic non-small cell lung cancer
    Pérol, M
    Moro-Sibilot, D
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : S131 - S136
  • [24] Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
    Arbour, Kathryn C.
    Riely, Gregory J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (08): : 764 - 774
  • [25] Systemic therapy of non-small cell lung cancer
    Griesinger, F.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2011, 25 (04): : 224 - 230
  • [26] Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer
    Xu Jing
    Liu Caixia
    Wu Xiaonan
    Ma Jie
    中华医学杂志英文版, 2023, 136 (15)
  • [27] Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient
    Karakas, Yusuf
    Yuce, Deniz
    Kilickap, Saadettin
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (10) : 621 - +
  • [28] Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer
    Xu, Jing
    Liu, Caixia
    Wu, Xiaonan
    Ma, Jie
    CHINESE MEDICAL JOURNAL, 2023, 136 (15) : 1765 - 1782
  • [29] Systemic Immune-Inflammatory Index as a Prognostic Biomarker in Patients with Heart Failure: A Comprehensive Analysis
    Abudouwayiti, Aihaidan
    Li, Yanxiao
    Tuerxun, Tumaresi
    Abudurexiti, Muyashaer
    Duan, Dongqin
    Zheng, Ying-Ying
    Mahemuti, Ailiman
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2025, 31
  • [30] Time-to-treatment for metastatic non-small cell lung cancer in the era of biomarker testing
    Akanbi, Maxwell Oluwole
    Kenmoe, Jerry
    Adekolujo, Samuel O.
    Saleem, Muhammad
    Koduru, Ujwala
    Hrinczenko, Borys
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)